Additionally, acute oxidative-stress-induced ROS promote the release of tumor antigens [110], activate dendritic cells (DCs) and CD8+ T cells [105,111], and enhance the efficacy of immune checkpoint inhibitors [112]. Here, CD8A is linked to neoplasm.